CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-23 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-04-23 | GIN JERRY B Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-04-23 | SAXE JON S Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-11-20 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Purchase | +15,000 | $0.34 | $5K | 15,000 |
| 2019-10-21 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2019-10-21 | MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-10-21 | Smith Mark Alan CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-10-21 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2019-10-21 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2019-10-21 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-10-21 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-10-21 | GIN JERRY B Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-10-21 | SAXE JON S Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-05-28 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2019-05-23 | SAXE JON S Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-05-23 | GIN JERRY B Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-05-23 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-05-23 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-05-23 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2019-05-23 | Smith Mark Alan CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 |
Page 8 of 17 · 323 trades